| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in PTCT over the last quarter tilts toward selling: insiders offloaded a net 112,078 shares worth roughly $7.8M. In the past 30 days, 0 insiders bought and 2 sold. The bias lately has been to the sell side.
All 2 insiders who sold still hold shares after their sales. Classified under Biotechnology (Health Care sector), PTCT's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.29M | $77.68M | -5,000 | |
| CEO | 383.9K | $26.32M | - | |
| VP | 105.3K | $6.76M | -2,265 | |
| CFO | 84.0K | $6.75M | - | |
| VP | 79.1K | $5.38M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Boulding Mark Elliott56 | Executive VP and CLO | Sale+OE10b5-1 | 10,462 | $78.65 | $822,867.75 | -9.0% | -16.4% | - | |
| Jun 10, 2026 | Pauwels Eric61 | Chief Business Officer | Sale+OE10b5-1 | 21,277 | $75.00 | $1,595,775.00 | -22.5% | -6.2% | - | |
| May 15, 2026 | Boulding Mark Elliott56 | Executive VP and CLO | Sale+OE10b5-1 | 2,812 | $72.18 | $202,958.00 | -2.6% | +0.7% | - | |
| May 14, 2026 | Klein Matthew B.53 | Chief Executive Officer | Sell10b5-1 | 12,572 | $72.95 | $917,153.54 | -3.1% | -0.1% | - | |
| May 8, 2026 | Boulding Mark Elliott56 | Executive VP and CLO | Sale+OE10b5-1 | 3,540 | $78.97 | $279,570.20 | -3.3% | -3.9% | - | |
| Apr 21, 2026 | Klein Matthew B.53 | Chief Executive Officer | Sell10b5-1 | 2,850 | $70.91 | $202,093.50 | -0.7% | +10.4% | - | |
| Apr 6, 2026 | Boulding Mark Elliott56 | Executive VP and CLO | Sale+OE10b5-1 | 2,265 | $69.45 | $157,293.27 | -2.1% | +24.0% | - | |
| Apr 2, 2026 | Golden Lee Scott | EVP &Chief Medical Officer | Sell10b5-1 | 829 | $67.99 | $56,363.71 | -1.0% | +20.0% | - | |
| Apr 1, 2026 | Almstead Neil Gregory55 | Chief Technical Ops Officer | Sell10b5-1 | 52,003 | $69.04 | $3,590,242.77 | -46.4% | +18.6% | - | |
| Mar 12, 2026 | Klein Matthew B.53 | Chief Executive Officer | Sell10b5-1 | 2,662 | $64.08 | $170,580.96 | -0.7% | +15.8% | - |